Difficulty: Medium
Average Score: 62%
Testbank
An infant receives surfactant via endotracheal (ET) tube at birth for symptoms of respiratory distress syndrome (RDS). When will the nurse anticipate seeing improvement of lung function?
Correct answer
B
Rationale
Improvement of lung function can be anticipated within 3 days after administering surfactant to an infant with respiratory distress syndrome.
Surfactant therapy is designed to reduce surface tension in the alveoli, promoting lung expansion and improving oxygenation. Typically, clinicians observe significant improvements in lung function within the first 72 hours following administration, as the surfactant begins to take effect and stabilize the infant's breathing.
A: Immediately – Improvement is not seen right away; it takes time for the surfactant to be effective and show noticeable changes in lung function.
C: 1 to 2 weeks – While some benefits may continue to develop, substantial improvement is generally expected much sooner than this timeframe.
D: At least 1 month – This duration is excessive, as significant changes in lung function are typically observed within days, not weeks or months.
Surfactant therapy is designed to reduce surface tension in the alveoli, promoting lung expansion and improving oxygenation. Typically, clinicians observe significant improvements in lung function within the first 72 hours following administration, as the surfactant begins to take effect and stabilize the infant's breathing.
A: Immediately – Improvement is not seen right away; it takes time for the surfactant to be effective and show noticeable changes in lung function.
C: 1 to 2 weeks – While some benefits may continue to develop, substantial improvement is generally expected much sooner than this timeframe.
D: At least 1 month – This duration is excessive, as significant changes in lung function are typically observed within days, not weeks or months.